Home LiteratureArticle Details
PMID: 2039202 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Mechanisms of quinolone resistance in a clinical isolate of Escherichia coli highly resistant to fluoroquinolones but susceptible to nalidixic acid.

Antimicrobial agents and chemotherapy ·Vol. 35 ·No. 3 ·1991-03-00 ·Pages 519-23

Moniot-Ville N, Guibert J, Moreau N, Acar JF, Collatz E, Gutmann L

Abstract

Two associated resistance mechanisms were found in a nalidixic acid-susceptible (4 micrograms/ml) but fluoroquinolone-resistant (8 to 16 micrograms/ml) strain of Escherichia coli Q2 selected under norfloxacin therapy. As compared with the susceptible E. coli Q1 isolated before treatment, changes in outer membrane proteins and lipopolysaccharides in Q2 were associated with a 1.5- to 3-fold decrease in the uptake of fluoroquinolones but not nalidixic acid. A 50% inhibition of DNA synthesis in toluene-permeabilized cells of the resistant strain E. coli Q2 required up to 500-fold increased quantities of fluoroquinolones, whereas such inhibition was obtained in both E. coli Q1 and Q2 with similar amounts of nalidixic acid. Selection from E. coli Q1 on norfloxacin of one-step resistant mutants resembling E. coli Q2 was unsuccessful. From these results we infer that a decrease in outer membrane permeability, associated with a peculiar alteration of the DNA gyrase, was responsible for the unusual quinolone resistance phenotype of E. coli Q2.

MeSH Terms
Anti-Infective Agents/pharmacokinetics,pharmacology DNA/biosynthesis Drug Resistance, Microbial Escherichia coli/drug effects,metabolism Humans Microbial Sensitivity Tests Nalidixic Acid/pharmacology Norfloxacin/pharmacokinetics,pharmacology
Chemicals
Anti-Infective Agents Nalidixic Acid DNA Norfloxacin
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Moniot-Ville N
Laboratoire de Microbiologie Médicale, Université Paris VI, France.
Guibert J
Moreau N
Acar J F
Collatz E
Gutmann L
References (19)
19 references, click to expand
  1. Escherichia coli K-12 mutants resistant to nalidixic acid: genetic mapping and dominance studies.
    J Bacteriol. 1969 Jul;99(1):238-41 PMID: 4895844
  2. Fluoroquinolone antimicrobial agents.
    Clin Microbiol Rev. 1989 Oct;2(4):378-424 PMID: 2680058
  3. Properties of the penicillin-binding proteins of Escherichia coli K12,.
    Eur J Biochem. 1977 Jan;72(2):341-52 PMID: 319999
  4. Mode of incomplete cross-resistance among pipemidic, piromidic, and nalidixic acids.
    Antimicrob Agents Chemother. 1978 Aug;14(2):240-5 PMID: 358918
  5. New nalidixic acid resistance mutations related to deoxyribonucleic acid gyrase activity.
    J Bacteriol. 1981 Nov;148(2):450-8 PMID: 6271730
  6. Inhibition of DNA replication in vitro by pefloxacin.
    FEBS Lett. 1982 Aug 23;145(2):355-9 PMID: 6751875
  7. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels.
    J Bacteriol. 1983 Apr;154(1):269-77 PMID: 6187729
  8. Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli.
    Antimicrob Agents Chemother. 1986 Apr;29(4):639-44 PMID: 3010850
  9. Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli.
    Antimicrob Agents Chemother. 1986 Mar;29(3):535-8 PMID: 3521490
  10. Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12.
    Antimicrob Agents Chemother. 1986 Aug;30(2):248-53 PMID: 3532944
  11. Mechanisms of action of and resistance to ciprofloxacin.
    Am J Med. 1987 Apr 27;82(4A):12-20 PMID: 3034057
  12. Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 1987 Apr;31(4):582-6 PMID: 3111356
  13. Accumulation of enoxacin by Escherichia coli and Bacillus subtilis.
    Antimicrob Agents Chemother. 1987 Sep;31(9):1348-54 PMID: 2823695
  14. Norfloxacin resistance in a clinical isolate of Escherichia coli.
    Antimicrob Agents Chemother. 1987 Oct;31(10):1640-1 PMID: 2829712
  15. Association between early inhibition of DNA synthesis and the MICs and MBCs of carboxyquinolone antimicrobial agents for wild-type and mutant [gyrA nfxB(ompF) acrA] Escherichia coli K-12.
    Antimicrob Agents Chemother. 1988 Aug;32(8):1113-8 PMID: 3056251
  16. Endogenous active efflux of norfloxacin in susceptible Escherichia coli.
    Antimicrob Agents Chemother. 1988 Aug;32(8):1187-91 PMID: 3056253
  17. Fluorometric assay for fleroxacin uptake by bacterial cells.
    Antimicrob Agents Chemother. 1989 Jan;33(1):27-9 PMID: 2540707
  18. Mechanisms of quinolone resistance in Escherichia coli: characterization of nfxB and cfxB, two mutant resistance loci decreasing norfloxacin accumulation.
    Antimicrob Agents Chemother. 1989 Mar;33(3):283-90 PMID: 2658782
  19. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
1991-03-00
Pages
519-23
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC245042
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]